De Gregori, S.; De Silvestri, A.; Cattadori, B.; Rapagnani, A.; Albertini, R.; Novello, E.; Concardi, M.; Arbustini, E.; Pellegrini, C.
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy in Heart Transplantation: New Strategies and Preliminary Results in Endomyocardial Biopsies. Pharmaceutics 2022, 14, 1247.
https://doi.org/10.3390/pharmaceutics14061247
AMA Style
De Gregori S, De Silvestri A, Cattadori B, Rapagnani A, Albertini R, Novello E, Concardi M, Arbustini E, Pellegrini C.
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy in Heart Transplantation: New Strategies and Preliminary Results in Endomyocardial Biopsies. Pharmaceutics. 2022; 14(6):1247.
https://doi.org/10.3390/pharmaceutics14061247
Chicago/Turabian Style
De Gregori, Simona, Annalisa De Silvestri, Barbara Cattadori, Andrea Rapagnani, Riccardo Albertini, Elisa Novello, Monica Concardi, Eloisa Arbustini, and Carlo Pellegrini.
2022. "Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy in Heart Transplantation: New Strategies and Preliminary Results in Endomyocardial Biopsies" Pharmaceutics 14, no. 6: 1247.
https://doi.org/10.3390/pharmaceutics14061247
APA Style
De Gregori, S., De Silvestri, A., Cattadori, B., Rapagnani, A., Albertini, R., Novello, E., Concardi, M., Arbustini, E., & Pellegrini, C.
(2022). Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy in Heart Transplantation: New Strategies and Preliminary Results in Endomyocardial Biopsies. Pharmaceutics, 14(6), 1247.
https://doi.org/10.3390/pharmaceutics14061247